All News #Library
Others
Toragen Gets Grant to Study TGN-S15 for Early Lesion Treatment
29 Oct 2025 //
BUSINESSWIRE
Toragen Announced Safety Data from Cohort 2 in Papillomavirus-Induced Cancer
12 Dec 2023 //
BUSINESSWIRE
Toragen Announced Positive Safety Update from Cohort 1 of its Phase 1 Trial
06 Nov 2023 //
BUSINESSWIRE
Toragen, Inc. Announced Full Enrollment of Cohort 1 of its Phase 1 Trial
10 Oct 2023 //
BUSINESSWIRE
Toragen, Inc. Announces Appointment of Chief Scientific Officer
08 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support